Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2019 | Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study | LANCET ONCOLOGY |